Effect of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Infants in China

NCT01373541 — Not applicable, Completed, 171 participants, Enzymotec

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Effect of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Infants in China: a Double Blind, Multi-center, Randomized, Controlled Trial

RegistryNCT01373541
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: triple, supportive care
Enrollment171 (Actual)
SponsorEnzymotec (Industry); collaborators: Biostime, Inc. (Guangzhou)
ConditionsHealth Behavior, Personal Satisfaction
InterventionsInFat™ based infant formula, Standard vegetable oil based infant formula (Other)
Datesstart 2011-05-01, primary completion 2012-12-01, completion 2013-05-01, first posted 2011-06-15, last updated 2014-02-13
Locations1 site in China

Related Papers Related Patents Related Grants Related Experts
All trials for Health Behavior All trials for Personal Satisfaction All trials of InFat™ based infant formula All trials of Standard vegetable oil based infant formula

-Summary

The purpose of this study is to determine the effect of infant formula with high percentage of palmitic acid at the sn-2 position (InFat™) on improving fat absorption and general gastrointestinal tolerance in Chinese formula-fed term infants.

Expand all sections  ·  Collapse all

+Detailed description

The purpose of this study is to assess the efficacy of infant formula with high percentage of palmitic acid at the sn-2 position (InFat™) as compared to standard vegetable oil based infant formula on general gastrointestinal tolerance and fat absorption, reducing calcium soaps formation and stool hardness in Chinese formula-fed term infants.

+Arms and interventions

ArmTypeInterventionsDescription
InFat groupActive comparatorOther: InFat™ based infant formulaInfant formula with structured triglycerides (high palmitic acid content at the sn-2 position)
Control groupActive comparatorOther: Standard vegetable oil based infant formulaInfant formula with standard vegetable blend (low palmitic acid content at the sn-2 position)
Referance groupNo interventionHuman milk breastfeeding
  • InFat™ based infant formula (Other), also known as high sn-2 palmitic acid, structured triglyceride: high sn-2 palmitic acid oil based infant formula
  • Standard vegetable oil based infant formula (Other), also known as standard vegetable oil: standard vegetable oil based infant formula

+Outcome measures

Primary outcomes

  • Soaped and total fatty acids content in infant's stool samples collected at the age of 6 weeks and measured by stool biochemistry analysis [6 postnatal weeks]

Secondary outcomes

  • Anthropometric parameters: body length, body weight, and head circumferences at each visit [Baseline, 6, 12 and 24 postnatal weeks]
  • Dietary, stool consistency and well being recorded by 3 day questionnaires [6, 12 and 24 postnatal weeks]
  • Number of participants with adverse events and concomitant medications as a measure of safety and tolerability [Baseline, 6,12 and 24 postnatal weeks]
  • Bone speed of sound measured by ultrasonic device at each visit [Baseline, 6,12 and 24 postnatal weeks]

+Eligibility

Sex: All, ages: 1 Day to 14 Days, accepts healthy volunteers

Inclusion Criteria:

* Parental/legal guardian written informed consent;
* The mother had unequivocally decided not to breast-feed (for formula fed infants) or to breastfeed (for human milk fed infants).
* Term infant of Chinese origin born at 37-42 gestation weeks
* Birth weight appropriate for gestational age (AGA), 2500-4000grams
* The infant is apparently healthy at birth and entry of study.

Exclusion Criteria:

* Adverse maternal, fetal or infant medical history that can potentially affect efficacy parameters, tolerance, growth and/or development
* The infant is not a singleton newborn

+Locations (1)

FacilityCityCountryStatus
Rui Jin Hospital - Shanghai Jiao Tong University School of MedicineShanghaiChina

+Publications

  • Results publication: Bar-Yoseph F, Lifshitz Y, Cohen T, Malard P, Xu C. SN2-Palmitate Reduces Fatty Acid Excretion in Chinese Formula-fed Infants. J Pediatr Gastroenterol Nutr. 2016 Feb;62(2):341-7. doi: 10.1097/MPG.0000000000000971. PMID 26334255

+Investigators